Rong Su

1.3k total citations · 1 hit paper
44 papers, 951 citations indexed

About

Rong Su is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Rong Su has authored 44 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Rong Su's work include Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Immune Cell Function and Interaction (5 papers) and Immune cells in cancer (5 papers). Rong Su is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Immune Cell Function and Interaction (5 papers) and Immune cells in cancer (5 papers). Rong Su collaborates with scholars based in China, Madagascar and United States. Rong Su's co-authors include Shusen Zheng, Haiyang Xie, Lin Zhou, Shengyong Yin, Junjie Qian, Qinchuan Wu, Tianchi Chen, Wuhua Zhou, Jian Wu and Liangjie Hong and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Rong Su

40 papers receiving 944 citations

Hit Papers

Mitochondrial TSPO Promotes Hepatocellular Carcinoma Prog... 2023 2026 2024 2025 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion
    2023 90 citations Da Man, Jiahua Lu et al. Advanced Science profile →

Peers

Rong Su
Zhifei Lin China
Jinghan Zhu China
Masayuki Nagahashi Japan
Guoan Xiang China
Jinxue Zhou China
Deqiang Wang China
Fang Xiong China
Xiongyan Wu China
Aiqun Liu China
Giusi Barra Italy
Zhifei Lin China
Rong Su
Citations per year, relative to Rong Su Rong Su (= 1×) peers Zhifei Lin

Countries citing papers authored by Rong Su

Since Specialization
Citations

This map shows the geographic impact of Rong Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong Su more than expected).

Fields of papers citing papers by Rong Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rong Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong Su. The network helps show where Rong Su may publish in the future.

Co-authorship network of co-authors of Rong Su

This figure shows the co-authorship network connecting the top 25 collaborators of Rong Su. A scholar is included among the top collaborators of Rong Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rong Su. Rong Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xiaojun, Congxin Huang, Rong Su, et al.. (2025). Developing a Panel of Shared Susceptibility Genes as Diagnostic Biomarkers for chronic obstructive pulmonary disease and Heart Failure. Computers in Biology and Medicine. 196(Pt A). 110657–110657.
2.
Luo, Jie, et al.. (2025). GNA15 induces drug resistance in B cell acute lymphoblastic leukemia by promoting fatty acid oxidation via activation of the AMPK pathway. Molecular and Cellular Biochemistry. 480(6). 3719–3733. 3 indexed citations
3.
4.
5.
Yu, Yongfeng, Dingzhi Huang, Hongming Pan, et al.. (2024). An open-label, multicenter, phase Ib/II study of the ATR inhibitor SC0245 in combination with irinotecan in patients with relapsed and refractory extensive stage small cell lung cancer (ES-SCLC).. Journal of Clinical Oncology. 42(16_suppl). 8102–8102. 1 indexed citations
6.
7.
Ru, Junnan, Jiahua Lu, Bo Ding, et al.. (2023). IRGM is a novel regulator of PD-L1 via promoting S6K1-mediated phosphorylation of YBX1 in hepatocellular carcinoma. Cancer Letters. 581. 216495–216495. 24 indexed citations
8.
Man, Da, Jiahua Lu, Yifan Jiang, et al.. (2023). Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion. Advanced Science. 10(15). e2206669–e2206669. 90 indexed citations breakdown →
9.
Qian, Junjie, Qinchuan Wu, Jing Mao, et al.. (2023). Blocking MARCO+ tumor-associated macrophages improves anti-PD-L1 therapy of hepatocellular carcinoma by promoting the activation of STING-IFN type I pathway. Cancer Letters. 582. 216568–216568. 24 indexed citations
10.
11.
Zhu, Ying, Hongjian Li, Rong Su, et al.. (2021). Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma. Molecular Medicine. 27(1). 15–15. 12 indexed citations
12.
Zhou, Ke, Xiaona Chen, Liang Zhang, et al.. (2021). Targeting peripheral immune organs with self-assembling prodrug nanoparticles ameliorates allogeneic heart transplant rejection. American Journal of Transplantation. 21(12). 3871–3882. 21 indexed citations
13.
Wang, Chen, Ting Yang, Jian Kang, et al.. (2020). Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS. Advances in Therapy. 37(4). 1591–1607. 9 indexed citations
14.
Huang, Ying, Pryseley Nkouibert Assam, Cong Feng, et al.. (2020). Ethnic pharmacokinetic comparison of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) between Asian and Western healthy subjects. Pulmonary Pharmacology & Therapeutics. 64. 101976–101976. 2 indexed citations
15.
Wang, Jiaming, et al.. (2020). Postoperative radiotherapy-induced leiomyosarcoma in breast cancer: a case report and literature review. Breast Cancer. 27(4). 780–784. 3 indexed citations
16.
He, Jianqin, Wenyi Chen, Rong Su, et al.. (2020). Characteristics and outcomes of acute-on-chronic liver failure patients with or without cirrhosis using two criteria. Scientific Reports. 10(1). 8577–8577. 5 indexed citations
17.
Xing, Chunyang, Wuhua Zhou, Songming Ding, et al.. (2012). Reversing Effect of Ring Finger Protein 43 Inhibition on Malignant Phenotypes of human Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 12(1). 94–103. 23 indexed citations
18.
Xing, Chunyang, Haiyang Xie, Lin Zhou, et al.. (2012). Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation. Biochemical and Biophysical Research Communications. 420(1). 29–35. 46 indexed citations
19.
Cheng, Jun, Haiyang Xie, Xiao Xu, et al.. (2011). NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma. Cancer Letters. 310(1). 35–45. 110 indexed citations
20.
Zhou, Huali, et al.. (2011). Roles of sulfonylurea receptor 1 and multidrug resistance protein 1 in modulating insulin secretion in human insulinoma. Hepatobiliary & pancreatic diseases international. 10(1). 88–94. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhifei Lin Breakdown of academic impact, for papers by Jinghan Zhu Breakdown of academic impact, for papers by Masayuki Nagahashi Breakdown of academic impact, for papers by Guoan Xiang Breakdown of academic impact, for papers by Jinxue Zhou Breakdown of academic impact, for papers by Deqiang Wang Breakdown of academic impact, for papers by Fang Xiong Breakdown of academic impact, for papers by Xiongyan Wu Breakdown of academic impact, for papers by Aiqun Liu Breakdown of academic impact, for papers by Giusi Barra
Rankless by CCL
2026